312 related articles for article (PubMed ID: 27213264)
1. Evolution of Bordetella pertussis.
He Q
Pediatr Infect Dis J; 2016 Aug; 35(8):915-7. PubMed ID: 27213264
[No Abstract] [Full Text] [Related]
2. Evolution of whooping cough bacterium may reduce vaccine effectiveness.
Riedmann EM
Hum Vaccin Immunother; 2014; 10(6):1430. PubMed ID: 25396233
[No Abstract] [Full Text] [Related]
3. Bordetella pertussis evolution in the (functional) genomics era.
Belcher T; Preston A
Pathog Dis; 2015 Nov; 73(8):ftv064. PubMed ID: 26297914
[TBL] [Abstract][Full Text] [Related]
4. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variation of Bordetella pertussis in Austria.
Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
[TBL] [Abstract][Full Text] [Related]
7. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
8. Bordetella pertussis strain variation and evolution postvaccination.
Kallonen T; He Q
Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
[TBL] [Abstract][Full Text] [Related]
9. Small mutations in Bordetella pertussis are associated with selective sweeps.
van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR
PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513
[TBL] [Abstract][Full Text] [Related]
10. [Modern strains of Bordetella pertussis: immunobiological properties and vaccine improvement].
Shinkarev AS; Mertsalova NU; Mazurova IK; Borisova OIu; Zakharova NS; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Britsina MV; Bazhanova IG
Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):20-5. PubMed ID: 17886371
[TBL] [Abstract][Full Text] [Related]
11. How Genomics Is Changing What We Know About the Evolution and Genome of Bordetella pertussis.
Ring N; Abrahams JS; Bagby S; Preston A; MacArthur I
Adv Exp Med Biol; 2019; 1183():1-17. PubMed ID: 31321755
[TBL] [Abstract][Full Text] [Related]
12. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
[TBL] [Abstract][Full Text] [Related]
13. Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959-2013.
Mosiej E; Krysztopa-Grzybowska K; Polak M; Prygiel M; Lutyńska A
J Med Microbiol; 2017 Jun; 66(6):753-761. PubMed ID: 28598302
[TBL] [Abstract][Full Text] [Related]
14. Bordetella pertussis, Finland and France.
Caro V; Elomaa A; Brun D; Mertsola J; He Q; Guiso N
Emerg Infect Dis; 2006 Jun; 12(6):987-9. PubMed ID: 16707058
[TBL] [Abstract][Full Text] [Related]
15. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.
Lam C; Octavia S; Ricafort L; Sintchenko V; Gilbert GL; Wood N; McIntyre P; Marshall H; Guiso N; Keil AD; Lawrence A; Robson J; Hogg G; Lan R
Emerg Infect Dis; 2014 Apr; 20(4):626-33. PubMed ID: 24655754
[TBL] [Abstract][Full Text] [Related]
16. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
[TBL] [Abstract][Full Text] [Related]
17. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
[TBL] [Abstract][Full Text] [Related]
18. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.
Hovingh ES; Mariman R; Solans L; Hijdra D; Hamstra HJ; Jongerius I; van Gent M; Mooi F; Locht C; Pinelli E
Emerg Microbes Infect; 2018 Mar; 7(1):39. PubMed ID: 29559630
[TBL] [Abstract][Full Text] [Related]
19. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
[TBL] [Abstract][Full Text] [Related]
20. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
Preston A
Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
